R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics

R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics

imedex

5 months
163 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Earn CME: https://naccme.com/program/7330 In this presentation from the 'CLL in the Era of Targeted Therapy' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Richard R. Furman utilizes a case presentation to examine personalized management strategies for relapsed/refractory, high risk patients with CLL. © 2019 Imedex, an HMP Company
Up Next Autoplay
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
Category: Lymphoma
1,009 Views
imedex 4 months
Update: Relapsed/Refractory Follicular Lymphoma
Update: Relapsed/Refractory Follicular Lymphoma
Category: Lymphoma
387 Views
imedex 4 months
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
Category: Lymphoma
324 Views
imedex 4 months
CAR-T in Lymphoma
CAR-T in Lymphoma
Category: Lymphoma
240 Views
imedex 4 months
Peripheral T-Cell Lymphoma: What is New on the Horizon?
Peripheral T-Cell Lymphoma: What is New on the Horizon?
Category: Lymphoma
226 Views
imedex 4 months
AML Case: A 54-year-old woman is in remission but MRD+
AML Case: A 54-year-old woman is in remission but MRD+
Category: Acute Myelogenous Leukemia
111 Views
imedex 5 months
Update: New Drugs for AML
Update: New Drugs for AML
Category: Acute Myelogenous Leukemia
175 Views
imedex 5 months
CLL: Sequencing Monotherapy vs. Combination Therapy
CLL: Sequencing Monotherapy vs. Combination Therapy
Category: Chronic Lymphocytic Leukemia
86 Views
imedex 5 months
Novel Treatment Options in CLL
Novel Treatment Options in CLL
Category: Chronic Lymphocytic Leukemia
137 Views
imedex 5 months